Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) FCF Margin (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of FCF Margin readings, the most recent being 2.38% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 32.0% to 2.38% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.32%, a 185.0% decrease, with the full-year FY2025 number at 1.32%, down 185.0% from a year prior.
  • FCF Margin hit 2.38% in Q4 2025 for Tandem Diabetes Care, down from 6.66% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 19.68% in Q1 2021 to a low of 13.22% in Q1 2023.
  • Median FCF Margin over the past 5 years was 2.54% (2024), compared with a mean of 2.43%.
  • Biggest five-year swings in FCF Margin: soared 4267bps in 2021 and later tumbled -2021bps in 2022.
  • Tandem Diabetes Care's FCF Margin stood at 9.31% in 2021, then tumbled by -217bps to 10.87% in 2022, then skyrocketed by 154bps to 5.81% in 2023, then plummeted by -53bps to 2.71% in 2024, then dropped by -12bps to 2.38% in 2025.
  • The last three reported values for FCF Margin were 2.38% (Q4 2025), 6.66% (Q3 2025), and 6.52% (Q2 2025) per Business Quant data.